ClinicalTrials.Veeva

Menu
E

Eternal Hospital | Clinical Research Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Empagliflozin
Darbepoetin Alfa
Olezarsen
Xarelto
Finerenone
Rivaroxaban

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 10 total trials

A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia

The purpose of this study is to evaluate the efficacy of olezarsen as compared to placebo on the percent change in fasting triglycerides (TG) from ba...

Active, not recruiting
Severe Hypertriglyceridemia
Drug: Placebo
Drug: Olezarsen

Finerenone works by blocking a group of proteins, called mineralocorticoid receptor. An increased stimulation of mineralocorticoid receptor is known...

Active, not recruiting
Chronic Kidney Disease
Type 2 Diabetes Mellitus
Drug: Finerenone (BAY94-8862 ) 20 mg
Drug: Finerenone Placebo

Trial sponsors

Bayer logo
Medtronic logo
Z
Ionis Pharmaceuticals logo
Medtronic logo
I
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems